Increased prostaglandin E2 (PGE2) levels in proliferative diabetic retinopathy, and correlation with VEGF and inflammatory cytokines.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Investigative Ophthalmology and Visual Science

• Publication date

  2012-08-27

• Fields of study

  Medicine

• Identifiers
  DOI 10.1167/iovs.12-10410PMID 22871833
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diabetic retinopathy.

  2012cited by this paper
• Serum levels of GRO‐α are elevated in association with disease activity in patients with Behçet’s disease

  2012cited by this paper
• Role of Intravitreal Inflammatory Cytokines and Angiogenic Factors in Proliferative Diabetic Retinopathy

  2012cited by this paper
• Reduced choroidal neovascular membrane formation in cyclooxygenase-2 null mice.

  2011cited by this paper
• Intraocular oxygen distribution in advanced proliferative diabetic retinopathy.

  2011cited by this paper
• Vitreous and serum levels of vascular endothelial growth factor and platelet‐derived growth factor and their correlation in patients with non‐proliferative diabetic retinopathy and clinically significant macula oedema

  2011cited by this paper
• Inflammatory markers in population studies of aging.

  2011cited by this paper
• Expression profiles of cytokines and chemokines in vitreous fluid in diabetic retinopathy and central retinal vein occlusion

  2011cited by this paper
• PRELIMINARY ASSESSMENT OF CELECOXIB AND MICRODIODE PULSE LASER TREATMENT OF DIABETIC MACULAR EDEMA

  2010cited by this paper
• Roles of endothelin-1 and selected proinflammatory cytokines in the pathogenesis of proliferative diabetic retinopathy: Analysis of vitreous samples.

  2010cited by this paper
• Nonsteroidal anti-inflammatory drugs in ophthalmology.

  2010cited by this paper
• CORRELATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR WITH CHEMOKINES IN THE VITREOUS IN DIABETIC RETINOPATHY

  2010cited by this paper
• Ketorolac inhibits choroidal neovascularization by suppression of retinal VEGF.

  2010cited by this paper
• The role of PGE2 receptor EP4 in pathologic ocular angiogenesis.

  2009cited by this paper
• Exploratory analysis of diabetic retinopathy progression through 3 years in a randomized clinical trial that compares intravitreal triamcinolone acetonide with focal/grid photocoagulation.

  2009cited by this paper
• Efficacy and pharmacokinetics of intravitreal non-steroidal anti-inflammatory drugs for intraocular inflammation

  2009cited by this paper
• VITREOUS NONSTEROIDAL ANTIINFLAMMATORY DRUG CONCENTRATIONS AND PROSTAGLANDIN E2 LEVELS IN VITRECTOMY PATIENTS TREATED WITH KETOROLAC 0.4%, BROMFENAC 0.09%, AND NEPAFENAC 0.1%

  2009cited by this paper
• Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.

  2008cited by this paper
• Immunological mechanisms in the pathogenesis of diabetic retinopathy

  2008influential reference
• The effect of long-term treatment with sulindac on the progression of diabetic retinopathy*

  2007influential reference
• Topical Administration of Nepafenac Inhibits Diabetes-Induced Retinal Microvascular Disease and Underlying Abnormalities of Retinal Metabolism and Physiology

  2007cited by this paper
• Single periocular injection of celecoxib-PLGA microparticles inhibits diabetes-induced elevations in retinal PGE2, VEGF, and vascular leakage.

  2006cited by this paper
• Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy

  2006cited by this paper
• Vitreous induces components of the prostaglandin E2 pathway in human retinal pigment epithelial cells.

  2003cited by this paper
• Celecoxib, a selective cyclooxygenase-2 inhibitor, inhibits retinal vascular endothelial growth factor expression and vascular leakage in a streptozotocin-induced diabetic rat model.

  2003cited by this paper
• Nonsteroidal anti‐inflammatory drugs prevent early diabetic retinopathy via TNF‐α suppression

  2002influential reference
• [Diabetic retinopathy].

  2001cited by this paper
• Human vitreal prostaglandin levels and proliferative diabetic retinopathy

  2001cited by this paper
• Regulation of TNFalpha and interleukin-10 production by prostaglandins I(2) and E(2): studies with prostaglandin receptor-deficient mice and prostaglandin E-receptor subtype-selective synthetic agonists.

  2001cited by this paper
• Cyclooxygenase-2 gene expression and regulation in human retinal pigment epithelial cells.

  2001cited by this paper
• Eotaxin and eosinophil recruitment: implications for human disease.

  2000cited by this paper
• Increased vasodilatory prostaglandin production in the diabetic rat retinal vasculature.

  1999influential reference
• Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38

  1998cited by this paper
• Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.

  1998cited by this paper
• Prostaglandin E2 induces vascular endothelial growth factor and basic fibroblast growth factor mRNA expression in cultured rat Müller cells.

  1998cited by this paper
• Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group.

  1995cited by this paper
• Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

  1994influential reference
• Nonsteroidal Anti-inflammatory Drugs in Ophthalmology

  1993influential reference
• The correlation between excessive vitreal protein levels, prostaglandin E2 levels, and the blood retinal barrier.

  1990cited by this paper
• Prostanoids in the vitreous of diabetic and nondiabetic human eyes with retinal detachment.

  1990cited by this paper
• Prostaglandin levels in human vitreous.

  1985cited by this paper
• DIABETIC RETINOPATHY AND RHEUMATOID ARTHRITIS.

  1964influential reference

• Hyperglycemia-induced oxidative stress in the development of diabetic retinopathy

  2025cites this paper
• Lipoxin A4 (LXA4) as a Potential Drug for Diabetic Retinopathy

  2025cites this paper
• Effects of Prostaglandin Analogue on the Central Retinal Thickness in Patients with Type 2 Diabetes Mellitus

  2025cites this paper
• Pathophysiological Mechanisms of Diabetes-Induced Macrovascular and Microvascular Complications: The Role of Oxidative Stress

  2025cites this paper
• Analysis of 24 pro-inflammatory cytokines in aqueous and serum of 94 patients without diabetes

  2025cites this paper
• Classification of Diabetic Retinopathy Severity with Aqueous VEGF Levels: A Prospective, Observational Study

  2025cites this paper
• Prostaglandin E2 stimulates opposing effects on inner and outer blood-retina barrier function

  2025cites this paper
• Analysis of Aqueous Interleukin-6 in Diabetic Retinopathy: A Prospective, Controlled Trial of 328 Eyes.

  2025cites this paper
• INflammatory MediatorS in the PathophysIology of Diabetic REtinopathy Study

  2025influential citation
• Inflammatory Mediators in the Pathophysiology of Diabetic Retinopathy (INSPIRE): Study Design and Baseline Characteristics

  2025cites this paper
• Machine Learning-Driven Identification of Hematological and Immunological Biomarkers for Predicting Proliferative Diabetic Retinopathy Progression

  2025cites this paper
• Potential of Pterostilbene as an Antioxidant Therapy for Delaying Retinal Damage in Diabetic Retinopathy

  2025cites this paper
• Cysteine-rich 61 mediates inflammation by the NF-κB/cyclooxygenase-2 pathway in RF/6A cells

  2025cites this paper
• Prostanoid signaling in retinal vascular diseases.

  2024cites this paper
• Molecular Mechanisms and Therapeutic Implications of Human Pericyte-like Adipose-Derived Mesenchymal Stem Cells in an In Vitro Model of Diabetic Retinopathy

  2024cites this paper
• Targeting inflammasomes and pyroptosis in retinal diseases-molecular mechanisms and future perspectives.

  2024cites this paper
• Prostanoid signaling in retinal cells elicits inflammatory responses relevant to early-stage diabetic retinopathy

  2024influential citation
• Proliferative Diabetic Retinopathy Microenvironment Drives Microglial Polarization and Promotes Angiogenesis and Fibrosis via Cyclooxygenase-2/Prostaglandin E2 Signaling

  2024cites this paper
• Indoxyl sulfate induces retinal microvascular injury via COX-2/PGE2 activation in diabetic retinopathy

  2024cites this paper
• Research Progress on the Etiology of Polypoid Choroidal Vascular Disease

  2024cites this paper
• Recent Insights into the Etiopathogenesis of Diabetic Retinopathy and Its Management

  2023cites this paper
• Arachidonic acid pathway in proliferative vitreoretinopathy: the study of the vitreous biomarker in rhegmatogenous retinal detachment

  2023cites this paper
• Synergic effects of EP2 and FP receptors co-activation on Blood-Retinal Barrier and Microglia.

  2023cites this paper
• Age-Related Macular Degeneration - Therapies and their delivery.

  2023cites this paper
• Serum metabolomics profiling of improved metabolic syndrome is characterized by decreased pro-inflammatory biomarkers: A longitudinal study in Chinese male adults.

  2023cites this paper
• The impact of intravitreal therapy of diabetic macular edema on the local and systemic production of cytokines

  2023cites this paper
• Ocular immune privilege and retinal pigment epithelial cells.

  2023cites this paper
• Changes in aqueous and vitreous inflammatory cytokine levels in proliferative diabetic retinopathy: a systematic review and meta-analysis

  2022cites this paper
• Harnessing retinal phagocytes to combat pathological neovascularization in ischemic retinopathies?

  2022influential citation
• Synergistic Effect of Combined Sub-Tenon Triamcinolone and Intravitreal Anti-VEGF Therapy for Uveitic Macular Edema

  2022cites this paper
• Concentrations of PGE2 and TXB2 in the Eyes of Mice with Disseminated Acanthamoebiasis

  2022cites this paper
• Comparison of the Effect of Bromfenac versus Betamethasone Ophthalmic Solutions in Patients with Diabetic Macular Edema

  2022cites this paper
• Exploring the pathogenesis of age-related macular degeneration: A review of the interplay between retinal pigment epithelium dysfunction and the innate immune system

  2022cites this paper
• Defibrinogenation Ameliorates Retinal Microgliosis and Inflammation in A CX3CR1-Independent Manner

  2022cites this paper
• Modification of erythrocyte membrane phospholipid composition in preterm newborns with retinopathy of prematurity: The omegaROP study

  2022cites this paper
• Neuroinflammation and neurodegeneration in diabetic retinopathy

  2022cites this paper
• Anti-CXCL10 monoclonal antibody therapy protects against the diabetic retinopathy in the mouse model induced by streptozotocin.

  2022cites this paper
• An overview of possible pivotal mechanisms of Genistein as a potential phytochemical against SARS‐CoV‐2 infection: A hypothesis

  2022cites this paper
• Toll-like receptor 2 and 6 agonist fibroblast-stimulating lipopeptide increases expression and secretion of CXCL1 and CXCL2 by uveal melanocytes.

  2022cites this paper
• Honey polyphenolic fraction inhibits cyclooxygenase-2 expression via upregulation of microRNA-26a-5p expression in pancreatic islets

  2022cites this paper
• Contact lenses for pravastatin delivery to eye segments: Design and in vitro-in vivo correlations.

  2022cites this paper
• Increased angiogenic factors in the aqueous and vitreous humors after disinsertion of extraocular muscle and the effects of triamcinolone acetate injection

  2022cites this paper
• Current understanding of the molecular and cellular pathology of diabetic retinopathy

  2021cites this paper
• Dynamic lipid turnover in photoreceptors and retinal pigment epithelium throughout life.

  2021cites this paper
• Correlation between ultrawide-field fluorescence contrast results and white blood cell indexes in diabetic retinopathy

  2021cites this paper
• Association between serum PGE2 levels and degree of acid-fast bacilli positivity in sputum of pulmonary tuberculosis patients

  2021cites this paper
• Gallic acid and myricetin-rich Labisia pumila extract mitigated multiple diabetic eye disorders in rats.

  2021cites this paper
• Review of the management of sight-threatening diabetic retinopathy during pregnancy

  2021cites this paper
• Potential Therapeutic Candidates for Age-Related Macular Degeneration (AMD)

  2021cites this paper
• The Vitreous Ecosystem in Diabetic Retinopathy: Insight into the Patho-Mechanisms of Disease

  2021influential citation
• Cultured Human Uveal Melanocytes Express/secrete CXCL1 and CXCL2 Constitutively and Increased by Lipopolysaccharide via Activation of Toll-like Receptor 4

  2021cites this paper
• Topical ketorolac as an adjunctive treatment with intravitreal bevacizumab in the management of diabetic macular edema: A double-masked placebo-controlled randomized clinical trial

  2021cites this paper
• HIF Inhibition Therapy in Ocular Diseases.

  2021cites this paper
• Prostaglandin E2 promotes pathological retinal neovascularisation via EP4R-EGFR-Gab1-AKT signaling pathway.

  2021cites this paper
• Analysis of Lipid Peroxidation by UPLC-MS/MS and Retinoprotective Effects of the Natural Polyphenol Pterostilbene

  2021cites this paper
• Oxidative stress and diabetic retinopathy: Molecular mechanisms, pathogenetic role and therapeutic implications

  2020cites this paper
• Prostaglandins as the Agents That Modulate the Course of Brain Disorders

  2020cites this paper
• Local and systemic production of 45 cytokines in complicated proliferative diabetic retinopaty

  2020influential citation
• Ocular nonsteroidal inflammatory drugs: where do we stand today?

  2020cites this paper
• Synthesis and structure-activity relationships of thieno[2,3-d]pyrimidines as atypical protein kinase C inhibitors to control retinal vascular permeability and cytokine-induced edema.

  2020cites this paper
• Levels of anti-insulin antibodies in diabetic retinopathy patients: an observational cross-sectional study

  2020cites this paper
• The role of IL-6-174 G/C polymorphism and intraocular IL-6 levels in the pathogenesis of ocular diseases: a systematic review and meta-analysis

  2020cites this paper
• Dysregulation of the NLRP3 Inflammasome in Diabetic Retinopathy and Potential Therapeutic Targets

  2020influential citation
• Cytokine Profiling in Patients With Exudative Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy.

  2019cites this paper
• Interleukin-6 and Diabetic Retinopathy: A Systematic Review and Meta-Analysis

  2019cites this paper
• The peroxisome proliferator-activated receptor-β/δ antagonist GSK0660 mitigates retinal cell inflammation and leukostasis.

  2019cites this paper
• VITREOUS PROSTAGLANDIN E2 CHANGES AFTER TOPICAL ADMINISTRATION OF DICLOFENAC 0.1%, INDOMETHACIN 0.5%, NEPAFENAC 0.3%, AND BROMFENAC 0.09.

  2019cites this paper
• Human vitreous in proliferative diabetic retinopathy: Characterization and translational implications.

  2019cites this paper
• Prostaglandin E2 Activates NLRP3 Inflammasome in Endothelial Cells to Promote Diabetic Retinopathy

  2018influential citation
• Inhibition of Ep3 attenuates migration and promotes apoptosis of non-small cell lung cancer cells via suppression of TGF-β/Smad signaling

  2018cites this paper
• Palmitic Acid Induces Müller Cell Inflammation that is Potentiated by Co-treatment with Glucose

  2018cites this paper
• Computational systems biology approach to identify novel pharmacological targets for diabetic retinopathy

  2018cites this paper
• Relationship between aqueous humor cytokine level changes and retinal vascular changes after intravitreal aflibercept for diabetic macular edema

  2018cites this paper
• Prostaglandin E2/EP2 receptor signalling pathway promotes diabetic retinopathy in a rat model of diabetes

  2018cites this paper
• Proliferative Diabetic Retinopathy: An Overview of Vitreous Immune and Biomarkers

  2018cites this paper
• Inflammation In The Pathogenesis Of Diabetic Retinopathy

  2018cites this paper
• An investigation into changes to trace metals and metabolic profiling in the diabetic retina

  2018cites this paper
• Use of nonsteroidal anti-inflammatory drugs in diabetic retinopathy.

  2017cites this paper
• Aflibercept treatment in patients with diabetic macular edema

  2017cites this paper
• Pharmacokinetics and efficacy of intraocular flurbiprofen

  2017cites this paper
• Infliximab relieves blood retinal barrier breakdown through the p38 MAPK pathway in a diabetic rat model.

  2017cites this paper
• In vivo studies validating multitargeting of prostanoid receptors for achieving superior anti‐inflammatory effects

  2017cites this paper
• The stabilizing effect of an oligomeric proanthocyanidin on red blood cell membrane structure of poorly controlled Type II diabetes

  2017cites this paper
• Inhibition of Stat3 by a Small Molecule Inhibitor Slows Vision Loss in a Rat Model of Diabetic Retinopathy

  2017cites this paper
• Assessment of biomarkers using multiplex assays in aqueous humor of patients with diabetic retinopathy

  2017cites this paper
• Obesity, metabolic syndrome and diabetic retinopathy: Beyond hyperglycemia

  2017cites this paper
• The opinion of the Expert Group of the Polish Society of Ophthalmology on using nepafenac in the prevention of postoperative macular edema after cataract surgery in diabetic patients.

  2017cites this paper
• Relationship between serum inflammatory markers and vascular function in a cohort of adolescents with type 1 diabetes

  2017cites this paper
• Sustained release of intravitreal flurbiprofen from a novel drug‐in‐liposome‐in‐hydrogel formulation☆

  2017cites this paper
• TNFα-Induced Disruption of the Blood-Retinal Barrier In Vitro Is Regulated by Intracellular 3',5'-Cyclic Adenosine Monophosphate Levels.

  2017cites this paper
• Effect of Topical Nepafenac on Central Foveal Thickness following Panretinal Photocoagulation in Diabetic Patients

  2017cites this paper
• Evolving Role of Regional Depot Corticosteroids in Management of Diabetic Macular Edema

  2017cites this paper
• MiR-18b suppresses high-glucose-induced proliferation in HRECs by targeting IGF-1/IGF1R signaling pathways.

  2016cites this paper
• New Drug Targets and Drug Delivery Strategies for Various Ocular Disorders

  2016cites this paper
• Viscoelasticity as a measurement of clot structure in poorly controlled type 2 diabetes patients: towards a precision and personalized medicine approach

  2016cites this paper
• REDUCTION OF VITREOUS PROSTAGLANDIN E2 LEVELS AFTER TOPICAL ADMINISTRATION OF INDOMETHACIN 0.5%, BROMFENAC 0.09%, AND NEPAFENAC 0.1%

  2016cites this paper
• Diabetic macular edema, retinopathy and age-related macular degeneration as inflammatory conditions

  2016cites this paper
• Safety and Feasibility of Quantitative Multiplexed Cytokine Analysis From Office-Based Vitreous Aspiration

  2016cites this paper
• Implication of oxidative stress in progression of diabetic retinopathy.

  2016cites this paper
• Lipid Mediators Are Critical in Resolving Inflammation: A Review of the Emerging Roles of Eicosanoids in Diabetes Mellitus

  2015cites this paper